HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom… - Aids, 2007 - journals.lww.com
Objectives: Monitoring regional levels of transmitted HIV-1 resistance informs treatment
guidelines and provides feedback on the success of HIV-1 prevention efforts. Surveillance …

Is HIV-1 evolving to a less virulent form in humans?

KK Ariën, G Vanham, EJ Arts - Nature Reviews Microbiology, 2007 - nature.com
During the rapid spread of HIV-1 in humans, the main (M) group of HIV-1 has evolved into
ten distinct subtypes, undergone countless recombination events and diversified …

High rates of forward transmission events after acute/early HIV-1 infection

BG Brenner, M Roger, JP Routy, D Moisi… - The Journal of …, 2007 - academic.oup.com
Background. A population-based phylogenetic approach was used to characterize human
immunodeficiency virus (HIV)—transmission dynamics in Quebec. Methods. HIV-1 pol …

Methamphetamine use and infectious disease‐related behaviors in men who have sex with men: implications for interventions

S Shoptaw, CJ Reback - Addiction, 2007 - Wiley Online Library
Aims Review the current evidence regarding the prevalence of methamphetamine use
among men who have sex with men (MSM) and to evaluate the factors that contribute to …

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

S Harada - Biochemical Journal, 2005 - portlandpress.com
Cell entry of enveloped viruses requires a wide-fusion-pore mechanism, involving clustering
of fusion-activated proteins and fluidization of the plasma membrane and viral envelope. In …

[HTML][HTML] Novel nanotechnology-based approaches for targeting HIV reservoirs

L Fotooh Abadi, F Damiri, M Zehravi, R Joshi, R Pai… - Polymers, 2022 - mdpi.com
Highly active anti-retroviral therapy (HAART) is prescribed for HIV infection and, to a certain
extent, limits the infection's spread. However, it cannot completely eradicate the latent virus …

Elevations in IL-10, TNF-α, and IFN-γfrom the Earliest Point of HIV Type 1 Infection

PJ Norris, BL Pappalardo, B Custer… - AIDS Research & …, 2006 - liebertpub.com
Perturbations of plasma IL-10, IL-12, IL-13, TNF-α, and IFN-γ were measured longitudinally
in HIV-1 seroconverting plasma donors and were compared to subjects with symptomatic …

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience

A Shet, L Berry, H Mohri, S Mehandru… - JAIDS Journal of …, 2006 - journals.lww.com
Transmitted resistance to antiretroviral drugs in acute and early HIV-1 infection has been
well documented, although overall trends vary depending on geography and cohort …

HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds

S Liu, S Wu, S Jiang - Current pharmaceutical design, 2007 - benthamdirect.com
HIV envelope glycoprotein transmembrane subunit gp41 plays a critical role in the fusion
between viral and target cell membranes. Upon gp120 binding to CD4 and a coreceptor …

Targeting anti-HIV drugs to the CNS

KS Rao, A Ghorpade, V Labhasetwar - Expert opinion on drug …, 2009 - Taylor & Francis
The development of antiretroviral drugs over the past couple of decades has been
commendable owing to the identification of several new targets within the overall HIV …